Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Sledge

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Cancer Investigation|March 11, 1999
Taxanes in the treatment of breast cancer: a prodigy comes of ageK D Miller, G W Sledge
Seminars in Oncology|September 12, 2001
Combined anthracycline-taxane regimens in the adjuvant settingE P Mamounas, G W Sledge
Advances in Cancer Research|January 1, 1983
Steroid hormone receptors in human breast cancerG W Sledge, W L McGuire
Advances in Dental Research|February 11, 1999
Effects of doxycycline on cancer cells in vitro and in vivoR S Fife, G W Sledge
Oncogene|May 22, 2001
Repression of GADD153/CHOP by NF-kappaB: a possible cellular defense against endoplasmic reticulum stress-induced cell deathS Nozaki, G W Sledge, H Nakshatri
Biochemical and Biophysical Research Communications|August 17, 2000
Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancerS Nozaki, G W Sledge, H Nakshatri
Cancer Letters|May 7, 1998
Effects of vitamin D3 on proliferation of cancer cells in vitroR S Fife, G W Sledge, C Proctor
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Redefining the target: chemotherapeutics as antiangiogenicsK D Miller, C J Sweeney, G W Sledge
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic eraK D Miller, C J Sweeney, G W Sledge
Breast Disease|February 3, 2005
Selection bias in clinical trialsK D Miller, Z U Rahman, G W Sledge
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Cancer Investigation|March 11, 1999
Taxanes in the treatment of breast cancer: a prodigy comes of ageK D Miller, G W Sledge
Seminars in Oncology|September 12, 2001
Combined anthracycline-taxane regimens in the adjuvant settingE P Mamounas, G W Sledge
Advances in Cancer Research|January 1, 1983
Steroid hormone receptors in human breast cancerG W Sledge, W L McGuire
Advances in Dental Research|February 11, 1999
Effects of doxycycline on cancer cells in vitro and in vivoR S Fife, G W Sledge
Oncogene|May 22, 2001
Repression of GADD153/CHOP by NF-kappaB: a possible cellular defense against endoplasmic reticulum stress-induced cell deathS Nozaki, G W Sledge, H Nakshatri
Biochemical and Biophysical Research Communications|August 17, 2000
Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancerS Nozaki, G W Sledge, H Nakshatri
Cancer Letters|May 7, 1998
Effects of vitamin D3 on proliferation of cancer cells in vitroR S Fife, G W Sledge, C Proctor
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Redefining the target: chemotherapeutics as antiangiogenicsK D Miller, C J Sweeney, G W Sledge
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic eraK D Miller, C J Sweeney, G W Sledge
Breast Disease|February 3, 2005
Selection bias in clinical trialsK D Miller, Z U Rahman, G W Sledge
Pageof 12